Cover Image
市場調查報告書

全球兒童疫苗市場未來趨勢

Global Pediatric Vaccine Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 317310
出版日期 內容資訊 英文 85 Pages
訂單完成後即時交付
價格
Back to Top
全球兒童疫苗市場未來趨勢 Global Pediatric Vaccine Market 2014-2018
出版日期: 2014年10月22日 內容資訊: 英文 85 Pages
簡介

兒童疫苗,用於各種感染疾病(白喉、流感、肝炎、肺炎球菌/腦膜炎疾病等)的幼兒、青少年疫苗接種。根據美國食品藥物管理局(FDA)定義,小兒科的對象年齡為0∼21歲(從新生兒到嬰兒、幼兒、青少年),不過,EMA(歐洲藥品管理局)定義為0∼18歲。全球兒童疫苗市場2013∼2018年的年複合成長率(CAGR)預計達到10.86%。

本報告提供全球的兒童疫苗市場相關分析、市場概要和結構、市場規模趨勢(今後5年的預測值)、各給藥途徑(口服藥/其他)、各產品種類、各地區的詳細趨勢、推動、阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查、考察。

第1章 摘要整理

第2章 簡稱集

第3章 分析範圍

  • 市場概要
  • 主要的產品

第4章 市場分析技術

  • 市場分析的流程
  • 分析方法

第5章 簡介

第6章 市場環境

  • 市場概況
  • 市場規模與其預測
  • 波特的五力分析

第7章 各給藥途徑的市場分析

  • 口服藥
  • 非口服藥

第8章 各產品種類的市場分析

  • 多糖類疫苗
  • 結合型疫苗

第9章 各地區的分析

  • 南北美洲市場
    • 市場規模與其預測
    • 美國市場
    • 南美市場
  • 歐洲、中東、非洲(EMEA)地區市場
    • 市場規模與其預測
    • 歐洲市場
  • 亞太地區市場
    • 市場規模與其預測
    • 中國市場
    • 印度市場
    • 日本市場

第10章 主要國家市場

  • 美國
  • 中國
  • 印度
  • 日本

第11章 購買標準

第12章 促進市場成長的要素

第13章 推動因素與其影響力

第14章 市場課題

第15章 推動因素、課題的影響力

第16章 市場趨勢

第17章 市場趨勢與其影響

第18章 供應商環境

  • 競爭方案
    • 近幾年的主要趨勢
    • 企業合併、收購(M&A)
  • 市場佔有率分析
    • GlaxoSmithKline
    • Sanofi
    • Pfizer
    • Merck
  • 其他的著名供應商

第19章 主要供應商分析

  • GlaxoSmithKline
    • 主要資料
    • 產業概要
    • 產業分類
    • 各部門的市場收益額(最新價值)
    • 各部門的市場收益額(與前年度的比較)
    • 各地區的市場收益額
    • 開發中產品
    • 產業策略
    • 近幾年趨勢
    • SWOT分析
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Sanofi

第20章 其他相關分析

圖表一覽

目錄
Product Code: IRTNTR4395

About Pediatric Vaccines

Pediatric vaccines are used for the immunization of children and adolescents against various infectious diseases, such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the US FDA, pediatric age ranges are classified as newborn, infant, child, and adolescent, ranging from birth to 21 years. However, the EMA classifies pediatric age range from birth to 18 years.

TechNavio's analysts forecast the Global Pediatric Vaccine market to grow at a CAGR of 10.25 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Pediatric Vaccine market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various approved vaccines.

TechNavio's report, the Global Pediatric Vaccine Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Pediatric Vaccine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi

Other Prominent Vendors

  • AstraZeneca
  • Bavarian Nordic
  • Baxter
  • Bharat Biotech
  • Bharat Immunologicals and Biologicals
  • bioCSL
  • Bio Med
  • Crucell
  • Dynavax Technologies
  • Indian Immunologicals
  • Janssen
  • Kaketsuken
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • Novartis
  • Nuron
  • Panacea Biotec
  • Serum Institute of India
  • Shenzhen Kangtai Biological Products
  • Sinovac Biotech
  • S K Chemicals
  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals
  • Zydus Cadila

Market Driver

  • Inclusion in National Immunization Schedule
  • For a full, detailed list, view our report

Market Challenge

  • Inadequate Vaccine Coverage
  • For a full, detailed list, view our report

Market Trend

  • Increase in Strategic Alliances
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Route of Administration

  • 07.1. Oral
  • 07.2. Parenteral

08. Market Segmentation by Product Type

  • 08.1. Polysaccharide Vaccines
  • 08.2. Conjugate Vaccines

09. Geographical Segmentation

  • 09.1. Pediatric Vaccine Market in Americas
    • 09.1.1. Market Size and Forecast
    • 09.1.2. Pediatric Vaccine Market in US
    • 09.1.3. Pediatric Vaccine Market in Latin America
  • 09.2. Pediatric Vaccine Market in EMEA
    • 09.2.1. Market Size and Forecast
    • 09.2.2. Pediatric Vaccine Market in Europe
  • 09.3. Pediatric Vaccine Market in APAC
    • 09.3.1. Market Size and Forecast
    • 09.3.2. Pediatric Vaccine Market in China
    • 09.3.3. Pediatric Vaccine Market in India
    • 09.3.4. Pediatric Vaccine Market in Japan

10. Key Leading Countries

  • 10.1. US
  • 10.2. China
  • 10.3. India
  • 10.4. Japan

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2013
    • 18.2.1. GlaxoSmithKline
    • 18.2.2. Sanofi
    • 18.2.3. Pfizer
    • 18.2.4. Merck
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. GlaxoSmithKline
    • 19.1.1. Key Facts
    • 19.1.2. Business Overview
    • 19.1.3. Business Segmentation
    • 19.1.4. Business Segmentation by Revenue 2012 and 2013
    • 19.1.5. Sales by Geography
    • 19.1.6. Pipeline Products
    • 19.1.7. Business Strategy
    • 19.1.8. Key Information
    • 19.1.9. SWOT Analysis
  • 19.2. Merck & Co. Inc.
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. Business Segmentation by Revenue 2013
    • 19.2.4. Business Segmentation by Revenue 2012 and 2013
    • 19.2.5. Sales by Geography
    • 19.2.6. Business Strategy
    • 19.2.7. Key Developments
    • 19.2.8. SWOT Analysis
  • 19.3. Pfizer Inc.
    • 19.3.1. Key Facts
    • 19.3.2. Business Description
    • 19.3.3. Business Segmentation
    • 19.3.4. Revenue by Business Segmentation
    • 19.3.5. Revenue Comparison 2012 and 2013
    • 19.3.6. Sales by Geography
    • 19.3.7. Business Strategy
    • 19.3.8. Key Developments
    • 19.3.9. SWOT Analysis
  • 19.4. Sanofi
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. Business Segmentation by Revenue 2013
    • 19.4.4. Business Segmentation by Revenue 2012 and 2013
    • 19.4.5. Geographical Segmentation by Revenue 2013
    • 19.4.6. Business Strategy
    • 19.4.7. Key Developments
    • 19.4.8. SWOT Analysis

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Pediatric Vaccine Market 2013-2018 (US$ billion)
  • Exhibit 3: Global Pediatric Vaccine Market Segmentation by Route of Administration
  • Exhibit 4: Global Pediatric Vaccine Market by Route of Administration 2013
  • Exhibit 5: Global Pediatric Vaccine Market Segmentation by Product Type
  • Exhibit 6: Global Pediatric Vaccine Market Segmentation by Product Type 2013
  • Exhibit 7: Global Pediatric Vaccine Market by Geographical Segmentation 2013
  • Exhibit 8: Global Pediatric Vaccine Market by Region/Country 2013
  • Exhibit 9: Pediatric Vaccine Market in Americas by Region/Country 2013
  • Exhibit 10: Pediatric Vaccine Market in Americas by Region/Country 2018
  • Exhibit 11: Pediatric Vaccine Market in Americas 2013-2018 (US$ billion)
  • Exhibit 12: Pediatric Vaccine Market in the US 2013-2018 (US$ billion)
  • Exhibit 13: Pediatric Vaccine Market in Latin America 2013-2018 (US$ billion)
  • Exhibit 14: Pediatric Vaccine Market in EMEA by Region 2013
  • Exhibit 15: Pediatric Vaccine Market in EMEA by Region 2018
  • Exhibit 16: Pediatric Vaccine Market in EMEA 2013-2018 (US$ billion)
  • Exhibit 17: Pediatric Vaccine Market in Europe 2013-2018 (US$ billion)
  • Exhibit 18: Pediatric Vaccine Market in APAC by Region 2013
  • Exhibit 19: Pediatric Vaccine Market in APAC by Region 2018
  • Exhibit 20: Pediatric Vaccine Market in APAC 2013-2018 (US$ billion)
  • Exhibit 21: Pediatric Vaccine Market in China 2013-2018 (US$ billion)
  • Exhibit 22: Pediatric Vaccine Market in India 2013-2018 (US$ billion)
  • Exhibit 23: Pediatric Vaccine Market in Japan 2013-2018 (US$ billion)
  • Exhibit 24: Comparison of Global Vaccine Market to Global Pediatric Vaccine Market 2013
  • Exhibit 25: Global Pediatric Vaccine Market Share Analysis 2013
  • Exhibit 26: GlaxoSmithKline's Revenue 2013
  • Exhibit 27: Sanofi's Revenue 2013
  • Exhibit 28: Pfizer's Revenue 2013
  • Exhibit 29: Merck's Revenue 2013
  • Exhibit 30: GlaxoSmithKline: Business Segmentation 2013
  • Exhibit 31: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 32: GlaxoSmithKline: Sales by Geography 2013
  • Exhibit 33: GlaxoSmithKline: Pipeline Products 2013
  • Exhibit 34: Merck & Co. Inc.: Business Segmentation by Revenue 2013
  • Exhibit 35: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 36: Merck & Co. Inc.: Sales by Geography 2013
  • Exhibit 37: Pfizer Inc.: Business Segmentation
  • Exhibit 38: Pfizer Inc.: Revenue by Business Segmentation 2013
  • Exhibit 39: Pfizer Inc.: Revenue by Business Segmentation 2012 and 2013
  • Exhibit 40: Pfizer Inc.: Revenue by Geography 2013
  • Exhibit 41: Sanofi: Business Segmentation by Revenue 2013
  • Exhibit 42: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 43: Sanofi: Geographical Segmentation by Revenue 2013
Back to Top